期刊
CIRCULATION RESEARCH
卷 97, 期 1, 页码 78-85出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.RES.0000173896.32522.6e
关键词
pyruvate dehydrogenase; delta PKC; pyruvate dehydrogenase kinase; free radicals; mitochondria; ischemia/reperfusion
资金
- NHLBI NIH HHS [2R01 HL-52141] Funding Source: Medline
- NIA NIH HHS [R01 AG-16339, R01 AG-19357] Funding Source: Medline
Cardiac ischemia and reperfusion are associated with loss in the activity of the mitochondrial enzyme pyruvate dehydrogenase ( PDH). Pharmacological stimulation of PDH activity improves recovery in contractile function during reperfusion. Signaling mechanisms that control inhibition and reactivation of PDH during reperfusion were therefore investigated. Using an isolated rat heart model, we observed ischemia-induced PDH inhibition with only partial recovery evident on reperfusion. Translocation of the redox-sensitive delta-isoform of protein kinase C (PKC) to the mitochondria occurred during reperfusion. Inhibition of this process resulted in full recovery of PDH activity. Infusion of the delta PKC activator H2O2 during normoxic perfusion, to mimic one aspect of cardiac reperfusion, resulted in loss in PDH activity that was largely attributable to translocation of delta PKC to the mitochondria. Evidence indicates that reperfusion-induced translocation of delta PKC is associated with phosphorylation of the alpha E1 subunit of PDH. A potential mechanism is provided by in vitro data demonstrating that delta PKC specifically interacts with and phosphorylates pyruvate dehydrogenase kinase (PDK)2. Importantly, this results in activation of PDK2, an enzyme capable of phosphorylating and inhibiting PDH. Thus, translocation of delta PKC to the mitochondria during reperfusion likely results in activation of PDK2 and phosphorylation-dependent inhibition of PDH.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据